These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26372746)

  • 1. Cutaneous Crohn's disease successfully treated with adalimumab.
    Stingeni L; Neve D; Bassotti G; Simonetti S; Bianchi L; Hansel K
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e72-e74. PubMed ID: 26372746
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab for the treatment of pediatric Crohn's disease.
    Nuti F; Fiorino G; Danese S
    Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.
    Louis EJ; Reinisch W; Schwartz DA; Löfberg R; Robinson AM; Berg S; Wang AW; Maa JF; Huang B; Pappalardo B
    Adv Ther; 2018 Apr; 35(4):563-576. PubMed ID: 29516410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Crohn's disease presenting as genital warts: successful treatment with adalimumab.
    Lestre S; Ramos J; João A; Serrão V
    Eur J Dermatol; 2010; 20(4):504-5. PubMed ID: 20507839
    [No Abstract]   [Full Text] [Related]  

  • 5. Adalimumab in pediatric Crohn's disease.
    Patel AS; Suarez LD; Rosh JR
    Immunotherapy; 2016 Feb; 8(2):127-33. PubMed ID: 26787222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
    Diamantova D; Lomickova I; Cetkovska P
    Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Crohn's disease treated with infliximab and 4 years of follow up.
    Yoong C; Schofield C; Rodins K; Faulkner C
    Australas J Dermatol; 2014 Aug; 55(3):e40-3. PubMed ID: 23772972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual case of duodenobiliary fistula complicating Crohn's disease successfully treated with Adalimumab.
    Hammami A; Slama AB; Jaziri H; Ameur WB; Mansour IB; Brahem A; Ajmi S; Jemni H; Ksiaa M; Jmaa A
    Arab J Gastroenterol; 2016 Dec; 17(4):188-190. PubMed ID: 27939339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of metastatic Crohn's disease with cyclosporine.
    Carranza DC; Young L
    J Drugs Dermatol; 2008 Aug; 7(8):789-91. PubMed ID: 18720698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic Crohn's disease. Response to adalimumab dose intensification].
    Lázaro Saéz M; Hernández Martínez A; Bendezú García RÁ; Rodríguez Manrique MA; Simón López F; Medina Estévez E; Vega Sáenz JL
    Gastroenterol Hepatol; 2012 May; 35(5):321-5. PubMed ID: 22445940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice.
    Echarri A; Ollero V; Barreiro-de Acosta M; Fernández-Villaverde A; Hernández V; Lorenzo A; Pereira S; Carpio D; Castro J;
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):430-5. PubMed ID: 25874517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab treatment failure in a case of cutaneous Crohn's disease.
    Yang DJ; Hsu S
    J Am Acad Dermatol; 2005 Nov; 53(5):903-4. PubMed ID: 16243156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cutaneous Crohn disease].
    Zampese MS; Bakos L; Kuhl IC; Wissbluth ML
    Med Cutan Ibero Lat Am; 1986; 14(3):205-11. PubMed ID: 3526048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Adalimumab in Korean Patients with Crohn's Disease.
    Sohn IW; Kim ST; Kim B; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Gut Liver; 2016 Mar; 10(2):255-61. PubMed ID: 26470766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miliary tuberculosis during adalimumab therapy in Crohn's disease.
    Ameneiros-Lago E; Vázquez Bueno JA; Garrido Sanjuan JA
    Med Clin (Barc); 2018 May; 150(10):412. PubMed ID: 28743405
    [No Abstract]   [Full Text] [Related]  

  • 16. Vulval Crohn's disease: a clinical study of 22 patients.
    Laftah Z; Bailey C; Zaheri S; Setterfield J; Fuller LC; Lewis F
    J Crohns Colitis; 2015 Apr; 9(4):318-25. PubMed ID: 25687208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing biological therapy in Crohn's disease.
    Gecse KB; Végh Z; Lakatos PL
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):37-45. PubMed ID: 26471077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus for recurrent penile Crohn's disease.
    Sánchez L; Cabanillas M; Alvarez JC; Echarri A
    J Crohns Colitis; 2014 Oct; 8(10):1145-6. PubMed ID: 24815787
    [No Abstract]   [Full Text] [Related]  

  • 19. Ramsay-Hunt Syndrome in a patient with Crohn's disease under adalimumab: first case report.
    Santos-Antunes J; Nunes AC; Macedo G
    Gastroenterol Hepatol; 2015; 38(7):443-4. PubMed ID: 25081200
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment.
    van den Reek JM; Pijls PA; Tummers M; van Riel PC; Kievit W; Hoentjen F; de Jong EM
    J Am Acad Dermatol; 2016 Jan; 74(1):177-9. PubMed ID: 26702800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.